IFN-γ-induced IDO and WRS expression in microglia is differentially regulated by IL-4

被引:48
作者
Yadav, Manisha C. [1 ]
Burudi, E. M. E. [1 ]
Alirezaei, Mehrdad [1 ]
Flynn, Claudia C. [1 ]
Lanigan, Caroline M. [1 ]
Fox, Howard S. [1 ]
机构
[1] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA
关键词
indoleamine 2,3-dioxygenase; tryptophanyl-tRNA synthetase; cytokine;
D O I
10.1002/glia.20544
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Indoleamine 2,3-dioxygenase (IDO), a tryptophan catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders. IDO expression is induced by IFN-gamma and leads to neurotoxicity by generating quinolinic acid. Additionally, it inhibits the immune response through both tryptophan depletion and generating other tryptophan catabolites. IL-4 and IL-13 have been shown to control IDO expression by antagonizing the effects of IFN-gamma in different cell types. Here, we investigated the effects of these cytokines on IDO expression in microglia. Interestingly, we observed that both IL-4 and IL-13 greatly enhanced IFN-gamma-induced IDO expression. However, tryptophanyl-tRNA synthetase (WRS), which is coinduced with IDO by IFN-gamma, is downregulated by IL-4 and IL-13. The effect of IL-4 and IL-13 was independent of STAT-6. Modulation of IDO but not VTRS was eliminated by inhibition of protein phosphatase 2A (PP2A) activity. The phosphatidylinositol 3-kinase (PI3K) pathway further differentiated the regulation of these two enzymes, as inhibiting the PI3K pathway eliminated IFN-gamma induction of IDO, whereas such inhibition greatly enhanced WRS expression. These findings show discordance between modulations of expression of two distinct enzymes utilizing tryptophan as a common substrate, and raise the possibility of their involvement in regulating immune responses in various neurological disorders. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1385 / 1396
页数:12
相关论文
共 65 条
  • [1] Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
    Ahmed, NN
    Grimes, HL
    Bellacosa, A
    Chan, TO
    Tsichlis, PN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3627 - 3632
  • [2] The IFN gamma receptor: A paradigm for cytokine receptor signaling
    Bach, EA
    Aguet, M
    Schreiber, RD
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 563 - &
  • [3] Kynurenic acid metabolism in the brain of HIV-1 infected patients
    Baran, H
    Hainfellner, JA
    Kepplinger, B
    Mazal, PR
    Schmid, H
    Budka, H
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (10) : 1127 - 1138
  • [4] INHIBITORY EFFECT OF A MARINE-SPONGE TOXIN, OKADAIC ACID, ON PROTEIN PHOSPHATASES - SPECIFICITY AND KINETICS
    BIALOJAN, C
    TAKAI, A
    [J]. BIOCHEMICAL JOURNAL, 1988, 256 (01) : 283 - 290
  • [5] Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells
    Boasso, A
    Herbeuval, JP
    Hardy, AW
    Winkler, C
    Shearer, GM
    [J]. BLOOD, 2005, 105 (04) : 1574 - 1581
  • [6] A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
    Braun, D
    Longman, RS
    Albert, ML
    [J]. BLOOD, 2005, 106 (07) : 2375 - 2381
  • [7] Role of interleukin-4 and monocyte chemoattractant protein-1 in the neuropathogenesis of X4 simian human immunodeficiency virus infection in macaques
    Buch, S
    Sui, YJ
    Potula, R
    Pinson, D
    Adany, I
    Li, Z
    Huang, MZ
    Li, SP
    Dhillon, N
    Major, E
    Narayan, O
    [J]. JOURNAL OF NEUROVIROLOGY, 2004, 10 : 118 - 124
  • [8] Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains
    Burudi, EME
    Marcondes, MCG
    Watry, DD
    Zandonatti, M
    Taffe, MA
    Fox, HS
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (23) : 12233 - 12241
  • [9] Chaves ACL, 2001, EUR J IMMUNOL, V31, P333, DOI 10.1002/1521-4141(200102)31:2&lt
  • [10] 333::AID-IMMU333&gt